Bereketeab Haileselassie1, Riddhita Mukherjee2, Amit U Joshi3, Brooke A Napier4, Liliana M Massis4, Nicolai Patrick Ostberg3, Bruno B Queliconi3, Denise Monack4, Daniel Bernstein5, Daria Mochly-Rosen3. 1. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: bhailes3@stanford.edu. 2. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. 3. Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. 4. Department of Microbiology, Stanford University School of Medicine, Stanford, CA 94305, USA. 5. Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract
Mitochondrial dysfunction is a key contributor to septic cardiomyopathy. Although recent literature implicates dynamin related protein 1 (Drp1) and its mitochondrial adaptor fission 1 (Fis1) in the development of pathologic fission and mitochondrial failure in neurodegenerative disease, little is known about the role of Drp1/Fis1 interaction in the context of sepsis-induced cardiomyopathy. Our study tests the hypothesis that Drp1/Fis1 interaction is a major driver of sepsis-mediated pathologic fission, leading to mitochondrial dysfunction in the heart. METHODS: H9C2 cardiomyocytes were treated with lipopolysaccharide (LPS) to evaluate changes in mitochondrial membrane potential, oxidative stress, cellular respiration, and mitochondrial morphology. Balb/c mice were treated with LPS, cardiac function was measured by echocardiogaphy, and mitochondrial morphology determined by electron microscopy (EM). Drp1/Fis1 interaction was inhibited by P110 to determine whether limiting mitochondrial fission can reduce LPS-induced oxidative stress and cardiac dysfunction. RESULTS: LPS-treated H9C2 cardiomyocytes demonstrated a decrease in mitochondrial respiration followed by an increase in mitochondrial oxidative stress and a reduction in membrane potential. Inhibition of Drp1/Fis1 interaction with P110 attenuated LPS-mediated cellular oxidative stress and preserved membrane potential. In vivo, cardiac dysfunction in LPS-treated mice was associated with increased mitochondrial fragmentation. Treatment with P110 reduced cardiac mitochondrial fragmentation, prevented decline in cardiac function, and reduced mortality. CONCLUSIONS: Sepsis decreases cardiac mitochondrial respiration and membrane potential while increasing oxidative stress and inducing pathologic fission. Treatment with P110 was protective in both in vitro and in vivo models of septic cardiomyopathy, suggesting a key role of Drp1/Fis1 interaction, and a potential target to reduce its morbidity and mortality.
Mitochondrial dysfunction is a key contributor to septic cardiomyopathy. Although recent literature implicates dynamin related protein 1 (Drp1) and its mitochondrial adaptor fission 1 (Fis1) in the development of pathologic fission and mitochondrial failure in neurodegenerative disease, little is known about the role of Drp1/Fis1 interaction in the context of sepsis-induced cardiomyopathy. Our study tests the hypothesis that Drp1/Fis1 interaction is a major driver of sepsis-mediated pathologic fission, leading to mitochondrial dysfunction in the heart. METHODS: H9C2 cardiomyocytes were treated with lipopolysaccharide (LPS) to evaluate changes in mitochondrial membrane potential, oxidative stress, cellular respiration, and mitochondrial morphology. Balb/c mice were treated with LPS, cardiac function was measured by echocardiogaphy, and mitochondrial morphology determined by electron microscopy (EM). Drp1/Fis1 interaction was inhibited by P110 to determine whether limiting mitochondrial fission can reduce LPS-induced oxidative stress and cardiac dysfunction. RESULTS: LPS-treated H9C2 cardiomyocytes demonstrated a decrease in mitochondrial respiration followed by an increase in mitochondrial oxidative stress and a reduction in membrane potential. Inhibition of Drp1/Fis1 interaction with P110 attenuated LPS-mediated cellular oxidative stress and preserved membrane potential. In vivo, cardiac dysfunction in LPS-treated mice was associated with increased mitochondrial fragmentation. Treatment with P110 reduced cardiac mitochondrial fragmentation, prevented decline in cardiac function, and reduced mortality. CONCLUSIONS: Sepsis decreases cardiac mitochondrial respiration and membrane potential while increasing oxidative stress and inducing pathologic fission. Treatment with P110 was protective in both in vitro and in vivo models of septic cardiomyopathy, suggesting a key role of Drp1/Fis1 interaction, and a potential target to reduce its morbidity and mortality.
Authors: Sonali Basu; Lowell H Frank; Kimberly E Fenton; Craig A Sable; Richard J Levy; John T Berger Journal: Pediatr Crit Care Med Date: 2012-05 Impact factor: 3.624
Authors: Marie-Hélène Disatnik; Julio C B Ferreira; Juliane Cruz Campos; Kátia Sampaio Gomes; Paulo M M Dourado; Xin Qi; Daria Mochly-Rosen Journal: J Am Heart Assoc Date: 2013-10-08 Impact factor: 5.501
Authors: Deanna K Sosnowski; K Lockhart Jamieson; Artiom Gruzdev; Yingxi Li; Robert Valencia; Ala Yousef; Zamaneh Kassiri; Darryl C Zeldin; John M Seubert Journal: Am J Physiol Heart Circ Physiol Date: 2022-08-19 Impact factor: 5.125
Authors: Leroy C Joseph; Michael V Reyes; Kundanika R Lakkadi; Blake H Gowen; Gyorgy Hasko; Konstantinos Drosatos; John P Morrow Journal: Am J Physiol Heart Circ Physiol Date: 2020-03-06 Impact factor: 4.733
Authors: Riddhita Mukherjee; Carly A Tompkins; Nicolai P Ostberg; Amit U Joshi; Liliana M Massis; Vijith Vijayan; Kanika Gera; Denise Monack; Timothy T Cornell; Mark W Hall; Daria Mochly-Rosen; Bereketeab Haileselassie Journal: Crit Care Med Date: 2022-01-24 Impact factor: 9.296